Treatment with larazotide acetate, a zonulin antagonist that enhances intestinal barrier integrity, was shown to effectively reduce arthritis onset, highlighting a preventive approach to autoimmune diseases by targeting intestinal barrier function [44]. The gene discussed is HP; the disease is autoimmune disease.